Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"The Lancet. Oncology"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22De+Giorgi%2C+Ugo%22&type=Person&filter%5B%5D=journalStr%3A%22The+Lancet.+Oncology%22
/vufind/Search/Results?lookfor=%22De+Giorgi%2C+Ugo%22&type=Person&filter%5B%5D=journalStr%3A%22The+Lancet.+Oncology%22
Search /vufind/Search2/Results?lookfor=%22De+Giorgi%2C+Ugo%22&type=Person&filter%5B%5D=journalStr%3A%22The+Lancet.+Oncology%22
PubPharm (15)
1
Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130) : final overall survival analysis results from a randomised, controlled, phase 3 study
enthalten in:
The Lancet. Oncology
| 2024
von
Grande, E.
|
Arranz, J.
|
De Santis, M.
| +20
Wird geladen...
2
Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130) : final overall survival analysis from a randomised, controlled, phase 3 study
enthalten in:
The Lancet. Oncology
| 2024
von
Bamias, A.
|
Davis, I.
|
Galsky, M.
| +21
Wird geladen...
3
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3) : a multicentre, open-label, randomised, controlled, phase 2 trial
enthalten in:
The Lancet. Oncology
| 2023
von
Pignata, S.
|
Scambia, G.
|
Schettino, C.
| +128
CommentIn: Lancet Oncol. 2023 Mar;24(3):201-203. - PMID 37052963
Wird geladen...
4
Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR) : extended follow-up from the phase 3, randomised, open-label study
enthalten in:
The Lancet. Oncology
| 2023
von
Choueiri, T.
|
Eto, M.
|
Motzer, R.
| +25
ErratumIn: Lancet Oncol. 2023 Apr;24(4):e146. - PMID 36990611
Wird geladen...
5
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564) : 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
enthalten in:
The Lancet. Oncology
| 2022
von
Powles, T.
|
Tomczak, P.
|
Park, S.
| +119
CommentIn: Lancet Oncol. 2022 Sep;23(9):1110-1111. - PMID 36055297
Wird geladen...
6
Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma : long-term follow-up of a phase 2 study
enthalten in:
The Lancet. Oncology
| 2022
von
Siefker-Radtke, A.
|
Necchi, A.
|
Park, S.
| +104
CommentIn: J Urol. 2022 Dec;208(6):1347-1349. - PMID 36111981
Wird geladen...
7
Talazoparib : a new biomarker-directed therapy in advanced prostate cancer
enthalten in:
The Lancet. Oncology
| 2021
von
Conteduca, V.
|
De Giorgi, U.
CommentOn: Lancet Oncol. 2021 Sep;22(9):1250-1264. - PMID 34388386
Wird geladen...
8
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6) : a multicentre, open-label, single-arm, phase 2 study
enthalten in:
The Lancet. Oncology
| 2021
von
Coleman, R.
|
Lorusso, D.
|
Gennigens, C.
| +51
Wird geladen...
9
Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer : a randomised, phase 3 trial
enthalten in:
The Lancet. Oncology
| 2021
von
Pignata, S.
|
Lorusso, D.
|
Joly, F.
| +62
Wird geladen...
10
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE) : a randomised, open-label, multicentre, phase 3 trial
enthalten in:
The Lancet. Oncology
| 2020
von
Powles, T.
|
van der Heijden, M.
|
Castellano, D.
| +127
ErratumIn: Lancet Oncol. 2021 Jan;22(1):e5. - PMID 33387509
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: The Lancet. Oncology
Medienart
15
Aufsätze
15
E-Artikel
15
E-Ressourcen
Zeitschriftentitel
The Lancet. Oncology
Thema
12
Journal Article
9
Randomized Controlled Trial
8
Research Support, Non-U.S. Gov't
7
Clinical Trial, Phase III
5
Comment
4
Antibodies, Monoclonal, Humanized
4
Multicenter Study
3
Clinical Trial, Phase II
3
Letter
2
52CMI0WC3Y
2
BG3F62OND5
2
Carboplatin
2
Comparative Study
2
DPT0O3T46P
2
P88XT4IS4D
2
Paclitaxel
2
Protein Kinase Inhibitors
2
atezolizumab
2
pembrolizumab
1
25X51I8RD4
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
10
2020-
5
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
15
Englisch
Haven't found what you're looking for?
Wird geladen...